A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 ...
Dec 3, 2025
0
0
The U.S. Department of Health and Human Services on Thursday outlined a strategy to expand its use of artificial intelligence, building on the Trump administration's enthusiastic embrace of the rapidly advancing technology ...
Dec 5, 2025
0
0
Tracking how genes switch on and off in the brain is essential for understanding many neurological diseases, yet the tools to monitor this activity are often invasive or unable to capture subtler changes over time. One emerging ...
Dec 3, 2025
0
56
Researchers at the University of Oxford and their collaborators have demonstrated that simple, rapid, and inexpensive tests can detect deadly contaminants in medicinal syrups—contaminants that have tragically led to the ...
Dec 4, 2025
0
4
More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening ...
Dec 9, 2025
0
0
Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the intensive chemotherapy often used, according to new research from Sylvester Comprehensive Cancer Center, ...
Dec 8, 2025
0
0
A new national study shows for the first time that people exposed to Agent Orange face a higher risk of developing myelodysplastic syndrome (MDS), tend to develop it earlier, and often have more aggressive disease that is ...
Dec 8, 2025
0
0
Cedars-Sinai investigators worked with a multi-institutional team to develop a new artificial intelligence framework that can accurately, quickly and efficiently create virtual models of brain neurons. The achievement could ...
Dec 8, 2025
0
0
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.
Dec 8, 2025
0
0
Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ability of people with diabetes and even prediabetes to better understand and control their blood ...
Dec 8, 2025
0
0
